About Pharmagreen Biotech Inc. (PHBI) data
Data as of May 29, 2026.
Pharmagreen Biotech Inc. (PHBI) has 197.25K shares sold short as of the latest FINRA settlement report on May 29, 2026. Short interest has decreased by 65.14% compared with the prior settlement. At the current average daily volume, covering all open short positions would take about 0.01 days (days to cover).
Recent PHBI short interest history
| Settlement date | Short interest | Change | Days to cover |
|---|---|---|---|
| May 29, 2026 | 197,247 | -65.14% | 1.00 |
| May 15, 2026 | 565,764 | 171.84% | 1.00 |
| Apr 30, 2026 | 208,123 | 296.26% | 1.00 |
| Apr 15, 2026 | 52,522 | 19.51% | 1.00 |
| Mar 31, 2026 | 43,948 | 3.14% | 1.00 |
| Mar 13, 2026 | 42,610 | 4.30% | 1.00 |
| Feb 27, 2026 | 40,853 | 1.34% | 1.00 |
| Feb 13, 2026 | 40,314 | 1.15% | 1.00 |
| Jan 30, 2026 | 39,856 | 8.14% | 1.00 |
| Jan 15, 2026 | 36,856 | 100.00% | 1.00 |
| Dec 15, 2025 | 16,050 | -92.60% | 1.00 |
| Nov 28, 2025 | 216,939 | -15.65% | 1.00 |
Full history, charts, and borrow-fee detail are on the PHBI short interest page.
Frequently asked questions
What is the current short interest in PHBI?
As of the latest FINRA settlement dated May 29, 2026, PHBI had approximately 197,247 shares sold short. Short interest data is reported by FINRA twice per month.
How much does it cost to short PHBI?
The latest borrow fee (cost to borrow) for PHBI is 0.32% per year, based on IBKR data. Fees can change throughout the trading day as shares are borrowed and returned.
What is the days to cover ratio for PHBI?
Days to cover for PHBI is approximately 0.01 days. This estimates how many trading days it would take short sellers to buy back all outstanding short shares at the current average daily volume.
Is PHBI a short squeeze candidate?
A squeeze needs shorts that are hard to close. PHBI trades about 17,187,022 shares a day and would take roughly 0.01 days to unwind current short positions, at a current borrow fee of 0.32%. Higher days-to-cover and a rising borrow fee together are the setup to watch; neither alone is enough.